Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome

Por Ritchie, Ellen K
Publicado em 2012

Food hygiene on board ship

Por Hobbs, Betty C., Ritchie, J. M., Ritchie, Ellen D.
Publicado em 1962

Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract

Por Kahn, Ryan M., Gordhandas, Sushmita, Chapman-Davis, Eloise, Margolskee, Elizabeth, Matrai, Cathleen, Chadburn, Amy, Ritchie, Ellen
Publicado no Case Rep Oncol Med (2019)

CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine

Por Allan, John N., Roboz, Gail J., Askin, Gulce, Ritchie, Ellen, Scandura, Joseph, Christos, Paul, Hassane, Duane C., Guzman, Monica L.
Publicado no Leuk Lymphoma (2017)

Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

Por Roboz, Gail J., Wissa, Usama, Ritchie, Ellen K., Gergis, Usama, Mayer, Sebastian, Scandura, Joseph M., Christos, Paul J., Feldman, Eric J.
Publicado em 2012

The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML)

Por Elliot, Kathleen, Tooze, Janet A., Geller, Rachel, Powell, Bayard L., Pardee, Timothy S., Ritchie, Ellen, Kennedy, LeAnne, Callahan, Kathryn E., Klepin, Heidi D.
Publicado em 2014

Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

Por Ritchie, Ellen K., Feldman, Eric J., Christos, Paul J., Rohan, Sarah D., Lagassa, Catherine B., Ippoliti, Cindy, Scandura, Joseph M., Carlson, Karen, Roboz, Gail J.
Publicado em 2013

Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemias or high-risk myelodysplastic syndromes

Por Roboz, Gail J., Khoury, H. Jean, Jabbour, Elias, Session, Wilena, Ritchie, Ellen K., Miao, Harry, Faderl, Stefan, Zheng, Wei, Feldman, Eric J., Arellano, Martha, Morrison, J. Gilmour, Ravandi, Farhad
Publicado no Leuk Lymphoma (2015)

Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

Por Mencia-Trinchant, Nuria, Hu, Yang, Alas, Maria Antonina, Ali, Fatima, Wouters, Bas J., Lee, Sangmin, Ritchie, Ellen K., Desai, Pinkal, Guzman, Monica L., Roboz, Gail J., Hassane, Duane C.
Publicado no J Mol Diagn (2017)

Somatic mutations precede acute myeloid leukemia years before diagnosis

Por Desai, Pinkal, Mencia-Trinchant, Nuria, Savenkov, Oleksandr, Simon, Michael S., Cheang, Gloria, Lee, Sangmin, Samuel, Michael, Ritchie, Ellen K., Guzman, Monica L., Ballman, Karla V., Roboz, Gail J., Hassane, Duane C.
Publicado no Nat Med (2018)

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk...

Por Feldman, Eric J., Lancet, Jeffrey E., Kolitz, Jonathan E., Ritchie, Ellen K., Roboz, Gail J., List, Alan F., Allen, Steven L., Asatiani, Ekatherine, Mayer, Lawrence D., Swenson, Christine, Louie, Arthur C.
Publicado no J Clin Oncol (2011)

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Por Scandura, Joseph M., Roboz, Gail J., Moh, Michelle, Morawa, Ewelina, Brenet, Fabienne, Bose, J. Robi, Villegas, Luis, Gergis, Usama S., Mayer, Sebastian A., Ippoliti, Cindy M., Curcio, Tania J., Ritchie, Ellen K., Feldman, Eric J.
Publicado em 2011

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

Por Roboz, Gail J., Ritchie, Ellen K., Dault, Yulia, Lam, Linda, Marshall, Danielle C., Cruz, Nicole M., Hsu, Hsiao-Ting C., Hassane, Duane C., Christos, Paul J., Ippoliti, Cindy, Scandura, Joseph M., Guzman, Monica L.
Publicado no Haematologica (2018)

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

Por Stein, Brady L., Oh, Stephen T., Berenzon, Dmitriy, Hobbs, Gabriela S., Kremyanskaya, Marina, Rampal, Raajit K., Abboud, Camille N., Adler, Kenneth, Heaney, Mark L., Jabbour, Elias J., Komrokji, Rami S., Moliterno, Alison R., Ritchie, Ellen K., Rice, Lawrence, Mascarenhas, John, Hoffman, Ronald
Publicado no J Clin Oncol (2015)

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy

Por Jacobs, Samantha E., Lamson, Daryl M., Soave, Rosemary, Guzman, Brigitte Huertas, Shore, Tsiporah B., Ritchie, Ellen K., Zappetti, Dana, Satlin, Michael J., Leonard, John P., Besien, Koen van, Schuetz, Audrey N., Jenkins, Stephen G., George, Kirsten St., Walsh, Thomas J.
Publicado no J Clin Virol (2015)

Incremental Utility of Right Ventricular Dysfunction in Patients with Myeloproliferative Neoplasm Associated Pulmonary Hypertension

Por Kim, Jiwon, Krichevsky, Spencer, Xie, Lola, Palumbo, Maria Chiara, Rodriguez-Diego, Sara, Yum, Brian, Brouwer, Lillian, Silver, Richard T., Schafer, Andrew I., Ritchie, Ellen K., Yabut, Maria Mia, Sosner, Claudia, Horn, Evelyn M., Devereux, Richard B., Scandura, Joseph M., Weinsaft, Jonathan W.
Publicado no J Am Soc Echocardiogr (2019)

Hematology and oncology clinical care during the coronavirus disease 2019 pandemic

Por Shah, Manish A., Emlen, M. Frances, Shore, Tsiporah, Mayer, Sebastian, Leonard, John P., Rossi, Adriana, Martin, Peter, Ritchie, Ellen, Niesvizky, Ruben, Pastore, Raymond, Cigler, Tessa, De Sancho, Maria, Scheff, Ronald, Van Besien, Koen, Roboz, Gail, Nanus, David, Goldstein, Paula, Scrimenti, Lara, Hidalgo, Manuel
Publicado no CA Cancer J Clin (2020)

Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: report of CALGB 361006 (Alliance)

Por Klepin, Heidi D., Ritchie, Ellen, Major-Elechi, Brittny, Le-Rademacher, Jennifer, Seisler, Drew, Storrick, Libby, Sanford, Ben L., Marcucci, Guido, Zhao, Weiqiang, Geyer, Susan A., Ballman, Karla V., Powell, Bayard L., Baer, Maria R., Stock, Wendy, Cohen, Harvey Jay, Stone, Richard M., Larson, Richard A., Uy, Geoffrey L.
Publicado no J Geriatr Oncol (2019)

Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response

Por Chaekal, Ok-kyong, Scaradavou, Andromachi, Masson Frenet, Emeline, Albano, Maria S., Cushing, Melissa, Desai, Pinkal, Dobrila, Ludy, Gergis, Usama, Guarneri, Danielle, Hsu, Jing-Mei, Lee, Sangmin, Mayer, Sebastian A., Phillips, Adrienne A., Orfali, Nina, Ritchie, Ellen K., Roboz, Gail J., Romeo, Cynthia, Samuel, Michael S., Shore, Tsiporah, van Besien, Koen
Publicado no Blood Adv (2020)

Phase I dose escalation study of lestaurtinib in patients with myelofibrosis

Por Hexner, Elizabeth O, Mascarenhas J, John, Prchal, Josef, Roboz, Gail J, Baer, Maria R, Ritchie, Ellen K, Leibowitz, David, Demakos, Erin P, Miller, Crystal, Siuty, James, Kleczko, Jill, Price, Leah, Jeschke, Grace, Weinberg, Rona, Basu T, Titiksha, Pahl, Heike L, Orazi, Attilio, Najfeld, Vesna, Marchioli, Roberto, Goldberg, Judith D, Silverman, Lewis R, Hoffman, Ronald
Publicado no Leuk Lymphoma (2015)